4 PEG-Based Value Stocks to Buy as Investors Look Beyond AI
Four value stocks stand out as investors look beyond AI, using PEG ratios, earnings growth and valuation metrics to find potential winners.
NVST - Envista Holdings Corp
Price:
--
--
|
CONSENSUS:
Hold
DETAILS
|
PRICE TARGET:
$29.14
DETAILS
HIGH:
$34.00
LOW:
$23.00
MEDIAN:
$29.00
CONSENSUS:
$29.14
UPSIDE:
7.41%
Stock News
Best Momentum Stocks to Buy for August 27th
ONTO, VIRT and NVST made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on August 27th, 2026.
New Strong Buy Stocks for August 27th
NVST, VIRT, ONTO, HMN and PROV have been added to the Zacks Rank #1 (Strong Buy) List on August 27th, 2026.
Why Envista (NVST) is a Top Value Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Envista (NVST) Upgraded to Strong Buy: Here's What You Should Know
Envista (NVST) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
NVST or ABT: Which Is the Better Value Stock Right Now?
Investors interested in Medical - Products stocks are likely familiar with Envista (NVST) and Abbott (ABT). But which of these two stocks presents investors with the better value opportunity right now?
Do Options Traders Know Something About Envista Stock We Don't?
Investors need to pay close attention to NVST stock based on the movements in the options market lately.
Best Value Stocks to Buy for August 24th
ZIM, FHI and NVST made it to the Zacks Rank #1 (Strong Buy) value stocks list on August 24th, 2026.
Deutsche Bank AG Takes $9.48 Million Position in Envista Holdings Corporation $NVST
Deutsche Bank AG purchased a new position in Envista Holdings Corporation (NYSE: NVST) in the undefined quarter, according to the company in its most recent disclosure with the SEC. The fund purchased 359,824 shares of the company's stock, valued at approximately $9,481,000. Deutsche Bank AG owned about 0.22% of Envista at the end
Are Investors Undervaluing Envista (NVST) Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
4 Stocks Trading Near 52-Week High With More Upside Potential
Stocks like NVST, RS, THG and LNVGY are seeing price strength and have a high chance of carrying the momentum forward.
Here's Why Envista (NVST) is a Strong Momentum Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Can NVST Sustain Its 2026 Guidance Boost as Margins Keep Expanding?
Envista raises 2026 guidance as stronger sales and expanding margins lift earnings, but China pricing, tariffs and a tougher Q4 loom.
Is NVST a Buy as Earnings Rebound but Valuation Remains Above Median?
Envista's earnings rebound and raised 2026 guidance strengthen the case, but above-median valuation leaves less room for execution setbacks.
4 Best PEG-Driven Value Stocks to Buy Now for Strong Returns
Four value stocks stand out for low PEG ratios, strong earnings growth prospects and favorable value scores, offering potential beyond traditional P/E screens.
Best Momentum Stocks to Buy for August 10th
AVT, GEO and NVST made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on August 10, 2026.
Investing in Envista (NVST)? Don't Miss Assessing Its International Revenue Trends
Examine the evolution of Envista's (NVST) overseas revenue trends and their effects on Wall Street's forecasts and the stock's prospects.
Best Growth Stocks to Buy for August 10th
VRT, NVST, and AER it to the Zacks Rank #1 (Strong Buy) growth stocks list on August 10, 2026.
Envista Q2 Earnings Call Highlights
Envista NYSE: NVST reported second-quarter 2026 sales of $731 million, supported by 5% core revenue growth and contributions from foreign exchange and acquisitions that lifted total revenue growth to just over 7%.
NVST vs. ABT: Which Stock Is the Better Value Option?
Investors interested in stocks from the Medical - Products sector have probably already heard of Envista (NVST) and Abbott (ABT). But which of these two stocks offers value investors a better bang for their buck right now?
Price Targets
Envista price target raised to $23 from $21 at Morgan Stanley
$23.00
(was $28.00)
Morgan Stanley
Envista price target raised to $34 from $31 at Baird
$34.00
(was $28.33)
Robert W. Baird
Envista price target raised to $29 from $27 at Mizuho
$29.00
(was $28.66)
Mizuho Securities
Envista price target raised to $26 from $25 at Piper Sandler
$26.00
(was $26.96)
Piper Sandler
Envista initiated with a Market Perform at BMO Capital
$27.00
(was $25.74)
Vik Chopra
·
BMO Capital
Envista price target lowered to $32 from $34 at Barclays
$32.00
(was $24.06)
Barclays
Envista price target raised to $33 from $30 at Evercore ISI
$33.00
(was $25.52)
Elizabeth Anderson
·
Evercore ISI
Envista price target raised to $31 from $30 at Baird
$31.00
(was $27.06)
Jeff Johnson
·
Robert W. Baird
Envista price target lowered to $30 from $32 at Evercore ISI
$30.00
(was $26.66)
Evercore ISI
Envista price target raised to $30 from $27 at Baird
$30.00
(was $28.36)
Robert W. Baird
Envista price target raised to $19 from $18 at Morgan Stanley
$19.00
(was $28.09)
Morgan Stanley
Envista price target raised to $32 from $26 at Evercore ISI
$32.00
(was $28.43)
Elizabeth Anderson
·
Evercore ISI
Envista price target raised to $31 from $27 at Stifel
$31.00
(was $24.71)
Stifel Nicolaus
Envista price target raised to $25 from $21 at Piper Sandler
$25.00
(was $24.71)
Jason Bednar
·
Piper Sandler
Leerink upgrades Envista to Outperform on improved growth, execution
$35.00
(was $24.71)
Leerink Partners
Envista price target raised to $27 from $25 at Stifel
$27.00
(was $23.27)
Jonathan Block
·
Stifel Nicolaus
Envista price target raised to $25 from $22 at UBS
$25.00
(was $23.26)
Kevin Caliendo
·
UBS
Envista price target raised to $21 from $19 at Piper Sandler
$21.00
(was $23.39)
Piper Sandler
Envista upgraded to Neutral from Underperform at Mizuho
$24.00
(was $25.24)
Steven Valiquette
·
Mizuho Securities
Envista initiated with an Overweight at Barclays
$24.00
(was $20.01)
Barclays